CTI BioPharma Corp (CTIC) has fallen Monday morning, with the stock decreasing -1.77% in pre-market trading to 4.44. CTIC's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, the stock ranks higher than 97% of stocks. CTI BioPharma Corp has risen 8.13% over the past month, closing at $4.08 on March 21. During this period of time, the stock fell as low as $4.08 and as high as $5.25. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.35.
CTIC has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on CTIC!